Загрузка...
CSIG-44. TREATMENT WITH THE CASEIN KINASE 2 INHIBITOR, CX-4945, SENSITIZES MEDULLOBLASTOMA TO TEMOZOLOMIDE
Medulloblastoma (MB) is the most common malignant pediatric brain tumor, accounting for ~20% of all cases. While current treatments result in a cure rate of 70–75%, the surviving patients are afflicted with neurocognitive impairment, endocrine dysfunction, and a severe decrease in quality of life. C...
Сохранить в:
| Опубликовано в: : | Neuro Oncol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216805/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.210 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|